Loading clinical trials...
Loading clinical trials...
Real-World Experience of Elagolix For the Treatment of Endometriosis in Canada: An Observational Cohort Study (GRACE)
Conditions
Locations
18
Canada
South Health Campus Rheumatology Clinic /ID# 213065
Calgary, Alberta, Canada
Aubrey D. Uretsky Professional Corporation /ID# 214753
Edmonton, Alberta, Canada
BC Women's Hospital /ID# 214561
Vancouver, British Columbia, Canada
Strand Clinic /ID# 213567
St. John's, Newfoundland and Labrador, Canada
IWK Health Center /ID# 213066
Halifax, Nova Scotia, Canada
Medicor Research Inc /ID# 213467
Greater Sudbury, Ontario, Canada
Start Date
December 4, 2019
Primary Completion Date
September 27, 2021
Completion Date
September 27, 2021
Last Updated
September 28, 2022
NCT05951452
NCT06611501
NCT05726786
NCT07241637
NCT04567771
NCT07215130
Lead Sponsor
AbbVie
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions